Survival, deaths and transplants in Canada, France, Australia and New Zealand (2015–2019; n=14 842)*
| Australia | Canada | France | New Zealand | |
| Total number of individuals, n | 3537 | 4434 | 6411 | 460 |
| Median age of survival, years (95% CI) | 53.3 (49.7 to 59.8) | 55.4 (51.3 to 59.2) | 65.9 (59.8 to 76.0) | 54.8 (40.7 to NA) |
| Transplants†, n (%) | 413 (11.7) | 589 (13.3) | 1061 (16.5) | 31 (6.7) |
| Paediatric, n (% of total transplants) | 20 (4.8) | 27 (4.6) | 99 (9.3) | 1 (3.2) |
| Adult, n (% of total transplants) | 393 (95.2) | 562 (95.4) | 962 (90.7) | 30 (96.8) |
| Age at transplant, years | 30.6 (24.8–38.3) | 29.7 (24.2–37.1) | 26.9 (22.2–33.6) | 30 (25.7–34.1) |
| Paediatric (≤18 years) | 15.2 (14.1–16.6) | 16 (14.5–16.9) | 16.1 (13.7–16.9) | 17 (17–17) |
| Adult (>18 years) | 31 (25.7–38.8) | 30.1 (24.9–37.6) | 28.1 (23.7–34.1) | 30.1 (25.8–34.2) |
| Deaths, n (%) | 178 (5) | 257 (5.8) | 241 (3.8) | 21 (4.6) |
| Death without transplant, n (% of total deaths) | 97 (54.5) | 149 (58) | 98 (40.7) | 16 (76.2) |
| Death after transplant, n (% of total deaths) | 81 (45.5) | 108 (42) | 143 (59.3) | 5 (23.8) |
| Age at death, years | 33.7 (25.4–44.1) | 34.7 (25.8–45.9) | 31.9 (24.3–41.9) | 34.7 (24.8–44.2) |
| Age at death without transplant, years | 32.4 (23.8–44) | 31.7 (22.7–45.4) | 30.3 (23.8–42.3) | 34.6 (26.6–45.4) |
| Age at death after transplant, years | 35.3 (26.8–44.1) | 38.8 (31.1–47.2) | 33 (25.1–41.5) | 35.7 (21.9–37.5) |
*Data are presented as median (IQR), unless indicated otherwise.
†This represents individuals who were followed in the registry between 2015 and 2019 and had received a transplant at any time point.
NA, not available.